STAT

Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...
STAT

End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costs

The White House decision to end a Medicare drug subsidy plays into Democratic arguments ahead of the midterms.
STAT

Fauci invokes Fifth Amendment in declining to answer questions before Senate panel

At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions about ...
STAT

FDA expert panel recommends against approval of Capricor’s Duchenne drug

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the ...
STAT

A neglected issue in pedestrian, biker deaths

Fauci's testimony, visa time limits for research students, and more health news from Morning Rounds ...
STAT

Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more

The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade ...
STAT

Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated

You might recall that in mid-June, there was a Nature Medicine study that pitted clinical AI systems OpenEvidence and ...
STAT

NSF testing new Ph.D. model giving trainees academic and industry experience

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Young life scientists have been increasingly abandoning academia, a seismic shift ...
STAT

Clinical chatbots are taking medicine by storm. Should doctors trust them?

As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and ...
STAT

Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. For decades, efforts to develop non-opioid pain drugs were marked by failure. But ...
STAT

Six key issues we’re watching at Fauci’s hearing

Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...
STAT

Hims misled consumers and violated their privacy, FTC alleges in a lawsuit

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...